Statins & Heart Health: 20% Risk Reduction in Seniors 75+
- New research from the University of Hong Kong (HKUMed) and harvard T.H.
- The study examined over 80,000 individuals in Hong Kong with suboptimal lipid levels and high-risk conditions.
- High cholesterol is a major concern, with a Hong Kong survey indicating that 65.6% of those aged 65-84 have elevated levels.
Harness the power of statins! Groundbreaking research reveals meaningful heart health benefits for seniors aged 75 and older. A new study highlights a 21% reduction in cardiovascular disease risk within five years for those using statin therapy, with even greater gains for individuals 85+. This major finding addresses critical gaps in existing clinical guidelines, showing that statins offer a safe and effective preventative measure. News Directory 3 is committed to delivering key updates that directly impact healthcare. Discover how statins can revolutionize senior wellness and learn how this research could reshape medical standards for the elderly. Discover what’s next …
Statins show Heart Benefits for Elderly, Study Finds
Updated June 20, 2025
New research from the University of Hong Kong (HKUMed) and harvard T.H. Chan School of Public health offers compelling evidence supporting the use of statins for elderly patients. The study, published in the Annals of Internal Medicine, found that continuous statin therapy significantly reduces the risk of cardiovascular diseases (CVDs) in individuals aged 75 and older.
The study examined over 80,000 individuals in Hong Kong with suboptimal lipid levels and high-risk conditions. Researchers discovered a 21% relative risk reduction in CVDs over five years for those aged 75-84 who consistently used statins. The benefit was even greater for those 85 and older, with a 35% relative risk reduction. Importantly, the study found no increased risk of liver dysfunction or myopathies associated with statin use in this population.
High cholesterol is a major concern, with a Hong Kong survey indicating that 65.6% of those aged 65-84 have elevated levels. While statins are commonly used to manage cholesterol, their role in primary prevention for those over 75 has been less clear due to limited depiction in clinical trials. This new research addresses that gap.
Professor Cindy Lam Lo-kuen of HKUMed emphasized the study’s importance for guiding clinical decisions. she also highlighted the innovative research method used, which could help answer other critical questions about geriatric care.
“these findings have significant implications for informing clinical decisions regarding the initiation of statin therapy for this increasingly large population group,” said Professor Lam Lo-kuen.
What’s next
Researchers hope this study will encourage wider use of statins for primary prevention of CVDs in older adults. The team also plans to use their research method to explore other unanswered questions in geriatric medicine,ultimately improving healthcare for the elderly.